FDA Clinical Trials Show 80% of Patients Are Spectacle FREE after surgery.
The AcrySof ReSTOR lens is a foldable IOL that represents breakthrough technology because of its unique, patented optic design, which allows patients to experience the highest level of freedom from glasses ever achieved in IOL clinical trials.
The AcrySof ReSTOR IOL uses a combination of three complementary technologies: apodization, diffraction and refraction, to allow patients to experience a full range of high-quality vision without the need for reading glasses or bifocals. This range of vision without glasses is achieved through the optical properties of the IOL.
The benefit for patients is a high level of spectacle freedom. Alcon has patented the application of apodization technology to an IOL, making the AcrySof ReSTOR lens the first and only apodized diffractive IOL.
During U.S. clinical trials, the results with ReSTOR were remarkable:
- 80% of patients reported that after lens implant surgery with ReSTOR lenses, they no longer needed glasses or contact lenses to see clearly at all distances.
- 94% said they could drive and read the paper without contacts or glasses.
- Nearly 94% were so satisfied that they would have the procedure again.
Ophthalmology website by Glacial Multimedia.